 Kala Pharmaceuticals, Inc. NASDAQ:KALA Q1 2022 Results Earnings Conference Call May 16, 2022 8:00 AM ET Company Participants Jill Steier - Executive Director, Investor Relations and Corporate Communications Mark Iwicki - Chairman and Chief Executive Officer Todd Bazemore - President and Chief Operating Officer Kim Brazzell - Head of RD and Chief Medical Officer Mary Reumuth - Chief Financial Officer Conference Call Participants Christopher Neyor - J.P. Morgan Francois Brisebois - Oppenheimer Co. Andreas Argyrides - Wedbush Securities Operator Good morning and welcome to Kala Pharmaceuticals Conference Call to Review its Fourth Quarter 2022 Financial Results. 